The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time

EuroIntervention 2019;15:e1041-e1045. DOI: 10.4244/EIJV15I12A196

1. Department of Cardiovascular Sciences, University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Centre, University Hospitals of Leicester Glenfield Hospital, Leicester, United Kingdom; 2. Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA


The last three decades have borne witness to the “reperfusion revolution” in patients with ST-elevation myocardial infarction (STEMI). Widespread acceptance of the concept proposed by Reimer and Jennings in 1979 that “time is muscle” has provided the impetus for the establishment of networks and systems of care to ensure the provision of rapid reperfusion therapy to as many patients as possible.

At the same time, epidemiological trends in high-income countries have seen a decline in the incidence of STEMI and a corresponding increase in the numbers of patients with non-ST elevation myocardial infarction (...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low surgical risk